Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma

International Journal of Urology

Volumn 15, Issue 9, 2008, Pages 794-799

  Obara, Wataru ^a   Mizutani, Yoichi ^b   Oyama, Chikara ^c   Akaza, Hideyuki ^d   Ishii, Nobuhisa ^e   Kohri, Kenjiro ^f   Namiki, Mikio ^g   Okuyama, Akihiko ^h   Shima, Hiroki ⁱ   Yokoyama, Masayoshi ^j   Shuin, Taro ^k   Miki, Tsuneharu ^b   Watanabe, Yoshiyuki ^b   Fujioka, Tomoaki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KOCHI MEDICAL SCHOOL   (Japan)

more..

Author keywords

Active vitamin D3; Combined immunotherapy; Metastatic renal cell carcinoma

Indexed keywords

ALFACALCIDOL; ALPHA INTERFERON;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCALCEMIA; KAPLAN MEIER METHOD; KIDNEY METASTASIS; LEUKOCYTE COUNT; LUNG METASTASIS; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, RENAL CELL; CHOLECALCIFEROL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMINS;

EID: 51349120651     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02086.x     Document Type: Article

References (17)

1. Motzer RJ, Bukowski RM. Targeted therapy for metastatic renal cell carcinoma. J. Clin. Oncol. 2006 24 : 5601 8.
2. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N. Engl. J. Med. 1996 335 : 865 75.
3. Motzer RJ, Bacik J, Murphy BA et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J. Clin. Oncol. 2002 20 : 289 96.
4. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 2003 3 : 601 14.
5. Spina CS, Tangpricha V, Uskokovic M et al. Vitamin D and cancer. Anticancer Res. 2006 26 : 2515 24.
6. Fujioka T, Suzuki Y, Okamoto T et al. Prevention of renal cell carcinoma by active vitamin D3. World J. Surg. 2000 24 : 1015 20.
7. Fujioka T, Hasegawa M, Ishikura K et al. Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma. J. Urol. 1998 160 : 247 51.
8. Feldman D, Malloy PJ, Gross C. Vitamin d: biology, action and clinical implications. In : Marcus R, Feldman D, Kelsey J (eds). Osteoporosis 1. Academic Press, San Diego, CA, 2001 257 304.
9. Buentig N, Stoerkel S, Richter E et al. Predictive impact of retinoid X receptor-alpha-expression in renal-cell carcinoma. Cancer Biother. Radiopharm. 2004 19 : 331 42.
10. Walsh PC, Retik AB, Vaughan ED et al. Campbell's Urology, 8th edn. Saunders, Philadelphia, 2002.
11. Reichrath J, Tilgen W, Diedrich K et al. Vitamin D analogs in cancer prevention and therapy. Anticancer Res. 2006 26 : 2511 14.
12. Flanigan RC, Salmon SE, Blumenstein BA et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N. Engl. J. Med. 2001 345 : 1655 9.
13. Mickisch GH, Garin A, van Poppel H et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001 358 : 966 70.
14. Atkins MB, Regan M, McDermott D. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin. Cancer Res. 2004 10 : 6342s 6s.
15. Aass N, De Mulder PH, Mickisch GH. Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma; the European Organization for Research and Treatment of Cancer, Genito-Urinary Tract Cancer Group (EORTC 30951). J. Clin. Oncol. 2005 23 : 4172 8.
16. Trump DL, Muindi J, Fakih M. Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res. 2006 26 : 2551 6.
17. Beer TM, Myrthue A. Calcitriol in the treatment of prostate cancer. Anticancer Res. 2006 26 : 2647 51.